About JOINN Company

The company is located in Beijing Economic and Technological Development Zone (Yizhuang). It was founded in August 1995. It is the national “12th Five-Year New Drug Creation” platform and the Beijing Key Laboratory for Drug Safety Evaluation. The Zhaoyan (Beijing) facility covers an area of 13,000 square meters, including 8,000 square meters of animal breeding management facilities. It has general grade, SPF animal rooms and biosafety level II (P2) laboratories (used to carry out research on low-level biohazardous drugs). Zhaoyan (Beijing) first passed the CFDA's GLP certification in 2005, passed the international AAALAC certification in 2008, passed the GLP on-site inspection by the US FDA in 2009, and passed the US FDA's GLP inspection again in 2013. Adhering to the vision of “serving drug innovation, focusing on safety evaluation and monitoring throughout the life cycle of drugs, ensuring patients' drug safety and caring for human health”, the company has established a golden industry chain with unique pre-clinical drug research services, clinical trials and related services, breeding and sales of high-quality experimental animals, and animal customization services using gene editing models. Drug preclinical research services are the company's core business. The main contents include drug nonclinical safety evaluation services, pharmacodynamics research services, animal pharmacokinetics research services, and drug screening (generally speaking, drug preclinical research services refer to services that evaluate, test, and research the safety, efficacy, quality control, etc. of test subjects before the clinical trial stage).